Suppr超能文献

利用 MALDI-TOF 质谱法鉴定γ重链病。

Identification of gamma heavy chain disease using MALDI-TOF mass spectrometry.

机构信息

Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, 327 E. 64th St., New York, NY 10065, USA.

Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, 327 E. 64th St., New York, NY 10065, USA.

出版信息

Clin Biochem. 2020 Mar;77:57-61. doi: 10.1016/j.clinbiochem.2019.12.010. Epub 2019 Dec 26.

Abstract

We describe the use of MALDI-TOF mass spectrometry in the analysis of a suspected case of gamma heavy chain disease. The patient had an abnormal serum immunofixation result where a monoclonal gamma heavy chain band was present without a corresponding light chain. Analysis by MALDI-TOF mass spectrometry revealed large peaks in the spectrum following IgG-specific purification. The m/z values of the peaks were outside the expected range for normal heavy chains or light chains. Corresponding peaks were not present in mass spectra of the kappa- or lambda-specific purifications. MALDI-TOF MS confirmed the presence of a truncated heavy chain without associated light chains. This case report demonstrates the value of mass spectrometry in interpreting challenging cases such as the identification of heavy chain disease.

摘要

我们描述了 MALDI-TOF 质谱分析在疑似γ重链病中的应用。该患者的血清免疫固定电泳结果异常,出现单克隆γ重链带,而没有相应的轻链。MALDI-TOF 质谱分析显示,在 IgG 特异性纯化后,图谱中出现了大的峰。峰的 m/z 值超出了正常重链或轻链的预期范围。κ或λ特异性纯化的质谱中没有相应的峰。MALDI-TOF MS 证实存在截断的重链,而没有相关的轻链。本病例报告证明了质谱在解释此类具有挑战性的病例(如重链病的鉴定)中的价值。

相似文献

1
Identification of gamma heavy chain disease using MALDI-TOF mass spectrometry.
Clin Biochem. 2020 Mar;77:57-61. doi: 10.1016/j.clinbiochem.2019.12.010. Epub 2019 Dec 26.
3
Detection of serum M-protein in acetonitrile precipitates by MALDI-TOF mass spectrometry: A novel, low-cost methodology.
Ann Clin Biochem. 2023 Sep;60(5):339-348. doi: 10.1177/00045632231174144. Epub 2023 May 9.
4
Direct Detection of Monoclonal Free Light Chains in Serum by Use of Immunoenrichment-Coupled MALDI-TOF Mass Spectrometry.
Clin Chem. 2019 Aug;65(8):1015-1022. doi: 10.1373/clinchem.2018.299461. Epub 2019 Jun 6.
5
MALDI-TOF mass spectrometry distinguishes daratumumab from M-proteins.
Clin Chim Acta. 2019 May;492:91-94. doi: 10.1016/j.cca.2019.02.017. Epub 2019 Feb 18.
6
MALDI-TOF mass spectrometry can distinguish immunofixation bands of the same isotype as monoclonal or biclonal proteins.
Clin Biochem. 2021 Nov;97:67-73. doi: 10.1016/j.clinbiochem.2021.08.001. Epub 2021 Aug 9.

本文引用的文献

1
Broad Bands Observed in Serum Electrophoresis Should Not Be Taken .
Clin Chem. 2019 May;65(5):618-621. doi: 10.1373/clinchem.2018.297176.
2
MALDI-TOF mass spectrometry distinguishes daratumumab from M-proteins.
Clin Chim Acta. 2019 May;492:91-94. doi: 10.1016/j.cca.2019.02.017. Epub 2019 Feb 18.
3
Two Cases of -Heavy Chain Disease and a Review of the Literature.
Case Rep Hematol. 2018 Aug 12;2018:4832619. doi: 10.1155/2018/4832619. eCollection 2018.
4
Restricted IgG-Kappa and Free Alpha-Heavy-Chain Bands in an Asymptomatic 62-Year-Old Man.
Clin Chem. 2018 Feb;64(2):265-268. doi: 10.1373/clinchem.2016.269050.
5
Heavy chain disease: our experience.
Clin Chem Lab Med. 2017 Nov 27;56(1):e10-e12. doi: 10.1515/cclm-2017-0254.
6
The utility of MASS-FIX to detect and monitor monoclonal proteins in the clinic.
Am J Hematol. 2017 Aug;92(8):772-779. doi: 10.1002/ajh.24772. Epub 2017 Jun 1.
7
Comprehensive Assessment of M-Proteins Using Nanobody Enrichment Coupled to MALDI-TOF Mass Spectrometry.
Clin Chem. 2016 Oct;62(10):1334-44. doi: 10.1373/clinchem.2015.253740. Epub 2016 Aug 18.
8
Analysis of patients with γ-heavy chain disease by the heavy/light chain and free light chain assays.
Clin Chem Lab Med. 2014 May;52(5):665-9. doi: 10.1515/cclm-2013-0714.
9
Gamma heavy chain disease in a patient with rheumatoid arthritis--a laboratory evaluation.
Biochem Med (Zagreb). 2012;22(3):373-9. doi: 10.11613/bm.2012.039.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验